Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialProteins containing the UBA domain are able to bind to multi-ubiquitin chains
Wilkinson, C. R. M., Seeger, M., Hartmann-Petersen, R., Stone, M., Wallace, M., Semple, C., & Gordon, C. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-939 · Cited by 407 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialThe UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway
Hofmann, K. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)30015-7 · Cited by 404 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialDarnay, B. G., Ni, J., Moore, P. A., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7724 · Cited by 399 · cited 2×
“Its binding is essential for RANK-induced NFkB activation (Darnay et al. 1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al.”
BackgroundAksentijevich, I., Galon, J., Soares, M., Mansfield, E., Hull, K., Oh, H.-H., Goldbach-Mansky, R., Dean, J., Athreya, B., Reginato, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321976 · Cited by 339 · cited 1×
“For other disorders, several authors already suggested that such mutational hotspots may explain recurrent mutations (Glaser et al. 1999; Rizzo et al. 1999; Aksentijevich et al. 2001; Lund et al. 2001).”
BackgroundPathophysiology and Treatment of Paget's Disease of Bone
Kanis, J. А. (1991) · Medical Entomology and Zoology · Cited by 308
Nuclear Inclusions in Paget's Disease of Bone
Mills, B. G., & Singer, F. R. (1976) · Science · doi:10.1126/science.959849 · Cited by 274 · cited 1×
“Within the pagetic lesion, osteoclasts are large, multinucleated, and overactive and contain paramyxovirus-like inclusions (Rebel et al. 1974; Mills and Singer 1976; Howatson and Fornasier 1982).”
BackgroundHuman Genetics: Lessons from Quebec Populations
Scriver, C. R. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.69 · Cited by 204
Siris, E. S. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1061 · Cited by 171
Koeberl, D. D., Bottema, C. D. K., Ketterling, R. P., Bridge, P. J., Lillicrap, D., & Sommer, S. S. (1990) · PubMed · Cited by 156
Genetic Linkage of Paget Disease of the Bone to Chromosome 18q
Cody, J. D., Singer, F. R., Roodman, G. D., Otterund, B., Lewis, T. B., Leppert, M., & Leach, R. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301601 · Cited by 151 · cited 1×
“3 (PDB1) and 18q21-22 (PDB2) (Fotino et al. 1977; Tilyard et al. 1982; Cody et al. 1997; Haslam et al. 1998).”
Paget Disease of Bone: Mapping of Two Loci at 5q35-qter and 5q31
Laurin, N., Brown, J. P., Lemainque, A., Duchesne, A., Huot, D., Lacourcière, Y., Drapeau, G., Verreault, J., Raymond, V., & Morissette, J. (2001) · The American Journal of Human Genetics · doi:10.1086/322975 · Cited by 139 · cited 12×
“A detailed clinical description of the families and clinical procedures has been presented elsewhere (Laurin et al. 2001).”
BackgroundMethodInfluentialSelf-citationHaslam, S. I., Hul, W. V., Morales-Piga, A. A., Balemans, W., San-Millan, J. L., Nakatsuka, K., Willems, P. J., Kingsbury, N., & Ralston, S. H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.911 · Cited by 138 · cited 4×
“As 13 of the 24 families investigated did not harbor any mutation in the SQSTM1/p62 coding sequence, it is likely that other disease gene(s) are also associated with PDB, in agreement with the well-established genetic heterogeneity of the disorder (Haslam et al. 1998; Hocking et al. 2001; Laurin et al. 2001; Good et a…”
BackgroundInfluentialRizzo, W. B., Carney, G., & Lin, Z. (1999) · The American Journal of Human Genetics · doi:10.1086/302681 · Cited by 126 · cited 1×
“For other disorders, several authors already suggested that such mutational hotspots may explain recurrent mutations (Glaser et al. 1999; Rizzo et al. 1999; Aksentijevich et al. 2001; Lund et al. 2001).”
BackgroundGenetic linkage of familial expansile osteolysis to chromosome 18q
Hughes, A. E., Shearman, A. M., Weber, J. L., Barr, R. J., Wallace, R. G. H., OSTERBERG, P. H., Nevin, N. C., & Mollan, R. A. B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.2.359 · Cited by 117 · cited 2×
“00 pansile osteolysis (FEO [MIM174810]) (Hughes et al. 1994), a rare bone dysplasia with some similarities to PDB.”
BackgroundInfluentialHocking, L. J., Herbert, C. A., Nicholls, R. K., Williams, F., Bennett, S. T., Cundy, T., Nicholson, G. C., Wuyts, W. A., Hul, W. V., & Ralston, S. H. (2001) · The American Journal of Human Genetics · doi:10.1086/323798 · Cited by 116 · cited 9×
“As 13 of the 24 families investigated did not harbor any mutation in the SQSTM1/p62 coding sequence, it is likely that other disease gene(s) are also associated with PDB, in agreement with the well-established genetic heterogeneity of the disorder (Haslam et al. 1998; Hocking et al. 2001; Laurin et al. 2001; Good et a…”
BackgroundInfluentialPathophysiology and treatment of Paget’s disease of the bone.
Stamp, L. (1999) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.81b3.0810562 · Cited by 111
Electronic PCR: bridging the gap between genome mapping and genome sequencing
Schuler, G. D. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01232-3 · Cited by 100 · cited 1×
“1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodPrinciples and practice of endocrinology and metabolism
Najjar, S. S. (1991) · Journal of Epilepsy · doi:10.1016/0896-6974(91)90086-x · Cited by 97
Familial Paget’s disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q
Hocking, L. J., Slee, F., Haslam, S. I., Cundy, T., Nicholson, G. C., Hul, W. V., & Ralston, S. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00278-7 · Cited by 87 · cited 2×
“However, the involvement of PDB1 and PDB2 may be restricted to only a few families, since linkage analyses excluded these two loci in the vast majority of the pagetic kindreds subsequently studied (Breanndan Moore and Hoffman 1988; Hocking et al. 2000; Nance et al. 2000; Good et al. 2001; Laurin et al. 2001).”
BackgroundLinkage of Paget Disease of Bone to a Novel Region on Human Chromosome 18q23
Good, D. M., Busfield, F., Fletcher, B. H., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338658 · Cited by 86 · cited 2×
“Indeed, we recently mapped 2 of these 13 families to a fourth locus for the disorder, PDB4, at 5q31 (Laurin et al. 2001), and there is evidence for three other loci associated with the disorder: PDB5 at 2q36, PDB6 at 10p13, and a locus at 18q23 (Hocking et al. 2001; Good et al. 2002).”
BackgroundGreen, P. M., Montandon, A. J., Bentley, D., Ljung, R. C. R., Nilsson, I. M., & Giannelli, F. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.11.3227 · Cited by 81 · cited 1×
“This mutation, occurring at a hypermutable CpG dinucleotide sequence (Green et al. 1990; Koeberl et al. 1990), might have arisen by deamination of a methylated cytosine.”
BackgroundEvidence for linkage between HLA and Paget's disease.
Fotino, M., Haymovits, A., & Falk, C. T. (1977) · PubMed · Cited by 79
Mouse models of abnormal skeletal development and homeostasis
McLean, W., & Olsen, B. R. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02458-1 · Cited by 64
A Probable Linkage Between Familial Paget's Disease and the HLA Loci*
Tilyard, M., Gardner, R. J. M., Milligan, L., Cleary, T., & Stewart, R. D. H. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb03830.x · Cited by 63 · cited 1×
“3 (PDB1) and 18q21-22 (PDB2) (Fotino et al. 1977; Tilyard et al. 1982; Cody et al. 1997; Haslam et al. 1998).”
Howatson, A. F., & Fornasier, V. (1982) · Intervirology · doi:10.1159/000149318 · Cited by 60 · cited 1×
“Within the pagetic lesion, osteoclasts are large, multinucleated, and overactive and contain paramyxovirus-like inclusions (Rebel et al. 1974; Mills and Singer 1976; Howatson and Fornasier 1982).”
BackgroundLund, A., Udd, B., Juvonen, V., Andersen, P. M., Cederquist, K., Davis, M. R., Gellera, C., Kölmel, C., Ronnevi, L., Sperfeld, A.-D., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200656 · Cited by 53 · cited 1×
“For other disorders, several authors already suggested that such mutational hotspots may explain recurrent mutations (Glaser et al. 1999; Rizzo et al. 1999; Aksentijevich et al. 2001; Lund et al. 2001).”
BackgroundThe Genetics of Paget's Disease of the Bone
Leach, R. J., Singer, F. R., & Roodman, G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7112 · Cited by 50
Ultrastructural characteristics of osteoclasts in Paget's disease.
Rebel, A., Malkani, K. V., Baslé, M. F., Brégeon, C., Patezour, A., & Filmon, R. (1974) · PubMed · Cited by 43
Good, D. M., Busfield, F., Duffy, D. L., Lovelock, P. K., Kesting, J. B., Cameron, D. P., & Shaw, J. T. E. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.33 · Cited by 36 · cited 3×
“However, the involvement of PDB1 and PDB2 may be restricted to only a few families, since linkage analyses excluded these two loci in the vast majority of the pagetic kindreds subsequently studied (Breanndan Moore and Hoffman 1988; Hocking et al. 2000; Nance et al. 2000; Good et al. 2001; Laurin et al. 2001).”
BackgroundDiagnostic Procedures for Paget’s Disease: Radiologic, Pathologic, and Laboratory Testing
Klein, R. M., & Norman, A. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30048-3 · Cited by 26 · cited 1×
“Paget disease of bone (PDB [MIM 167250]) is a chronic disease of the skeleton that affects up to 2%–3% of the population aged 140 years (Siris and Canfield 1990; Klein and Norman 1995).”
BackgroundHeterogeneity in Paget disease of the bone
Nance, M. A., Nuttall, F. Q., Econs, M. J., Lyles, K. W., Viles, K. D., Vance, J. M., Pericak-Vance, M. A., & Speer, M. C. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000619)92:5<303::aid-ajmg2>3.0.co;2-e · Cited by 24
Absence of HLA linkage in a family with osteitis deformans (Paget's disease of bone)
Moore, S. B., & Hoffman, D. L. (1988) · Tissue Antigens · doi:10.1111/j.1399-0039.1988.tb02065.x · Cited by 19 · cited 1×
“…involvement of PDB1 and PDB2 may be restricted to only a few families, since linkage analyses excluded these two loci in the vast majority of the pagetic kindreds subsequently studied (Breanndan Moore and Hoffman 1988; Hocking et al. 2000; Nance et al. 2000; Good et al. 2001; Laurin et al. 2001).”
BackgroundClinical Features and Pharmacologic Treatment of Paget’s Disease
Hamdy, R. C. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30047-1 · Cited by 14 · cited 1×
“The disorder is characterized by focal areas of increased and disorganized bone turnover, leading to bone pain, deformity, pathological fracture, neurological complications, and an increased risk of osteosarcoma (Hamdy 1995; Kanis 1998).”
BackgroundSiris, E. S., & Canfield, R. E. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(91)90026-j · Cited by 10
(1999) · doi:10.1002/(sici)1098-1004(1999)14:1
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Autophagy: process and function
Mizushima, N. (2007) · Genes & Development · doi:10.1101/gad.1599207 · Cited by 3,967
“2007) and is mutated in Paget disease patients (Laurin et al. 2002).”
BackgroundAutophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.